Effects of physical and mind–body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis Charlotte KreutzMartina E. SchmidtKaren Steindorf Review 06 April 2019 Pages: 1 - 15
Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review Michael CooryKate Thornton Review 12 April 2019 Pages: 17 - 25
Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer I. NoordhoekA. F. de GrootJ. R. Kroep Review Open access 17 April 2019 Pages: 27 - 36
Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer Kamran Ahmad KhanBruno MazuquinJulie Bruce Review Open access 17 April 2019 Pages: 37 - 52
The relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies Narjes BahriTahereh Fathi NajafiAbdoljavad Khajavi Review 19 April 2019 Pages: 53 - 61
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer Sasagu KurozumiChitra JosephEmad A. Rakha Preclinical study 02 April 2019 Pages: 63 - 73
Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues Hiroki KusamaMasafumi ShimodaShinzaburo Noguchi Preclinical study 04 April 2019 Pages: 75 - 85
Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm Yuanyuan LuJunlai LiErlong Fan Preclinical study Open access 05 April 2019 Pages: 87 - 94
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer Martin MutongaSedona SpeedyCesar A. Santa-Maria Preclinical Study 11 April 2019 Pages: 95 - 100
Pathologic discordance to clinical management decisions suggests overtreatment in pediatric benign breast disease Maggie L. WestfalNuma P. PerezCassandra M. Kelleher Preclinical study 13 April 2019 Pages: 101 - 108
Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression Xiaobin MaChengxue DangHuafeng Kang Preclinical study 15 April 2019 Pages: 109 - 117
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway Jieun LeeHee Eun KimAhwon Lee Preclinical study Open access 15 April 2019 Pages: 119 - 130
Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures Peng MengMarica VaapilPaul Yaswen Preclinical study 16 April 2019 Pages: 131 - 140
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants D. Gareth R. EvansElaine F. HarknessJack Cuzick Clinical trial Open access 02 April 2019 Pages: 141 - 148
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event Lucile MontagneJocelyn GalJean-Michel Hannoun-Levi Clinical trial 04 April 2019 Pages: 149 - 157
Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy Kassandra NealonMegan RebelloMichelle Specht Clinical trial 11 April 2019 Pages: 159 - 164
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms Rinat Bernstein-MolhoAmihood SingerEitan Friedman Clinical trial 12 April 2019 Pages: 165 - 170
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases Daniel N. CagneyNayan LambaAyal A. Aizer Clinical trial 13 April 2019 Pages: 171 - 179
Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study Bihong T. ChenTaihao JinWilliam Dale Clinical trial 13 April 2019 Pages: 181 - 189
Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women Serena C. HoughtonA. Heather EliassenSusan E. Hankinson Epidemiology 06 April 2019 Pages: 191 - 203
Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference? Joan M. NeunerAnn B. NattingerLiliana E. Pezzin Epidemiology 10 April 2019 Pages: 205 - 215
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer Dominique J. P. van UdenMarissa C. van MaarenJohannes H. W. de Wilt Epidemiology Open access 10 April 2019 Pages: 217 - 226
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1) Luis Baez-VallecilloAkshara S. RaghavendraRashmi K. Murthy Epidemiology 11 April 2019 Pages: 227 - 234
The association between mammographic density and breast cancer risk in Western Australian Aboriginal women Ellie DarceyRachel LloydJennifer Stone Epidemiology 12 April 2019 Pages: 235 - 242
Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients Diana Flores-DíazClaudia ArceAlejandro Mohar Epidemiology 17 April 2019 Pages: 243 - 249
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer Jangsoon LeeBora LimNaoto T. Ueno Correction 15 April 2019 Pages: 251 - 251